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The control of vancomycin-resistant enterococci (VRE) has become an increasing burden on health care resources since their
discovery over 20 years ago. Current techniques employed for their detection include time-consuming and laborious phenotypic
methods or molecular methods requiring costly equipment and consumables and highly trained staff. An accurate, rapid diag-
nostic test has the ability to greatly reduce the spread of this organism, which has the ability to colonize patients for long peri-
ods, potentially even lifelong. Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) is
a technology with the ability to identify organisms in seconds and has shown promise in the identification of other forms of anti-
microbial resistance in other organisms. Here we show that MALDI-TOF MS is capable of rapidly and accurately identifying
vanB-positive Enterococcus faecium VRE from susceptible isolates. Internal validation of the optimal model generated produced
a sensitivity of 92.4% and a specificity of 85.2%. Prospective validation results, following incorporation into the routine labora-
tory work flow, demonstrated a greater sensitivity and specificity at 96.7% and 98.1%, respectively. In addition, the utilization of
MALDI-TOF MS to determine the relatedness of isolates contributing to an outbreak is also demonstrated.
Glycopeptide antibiotics, particularly vancomycin, have formany years been the mainstay of treatment for increasingly
antibiotic-resistant Gram-positive organisms, including entero-
cocci. Since their discovery in the late 1980s, vancomycin-resistant
enterococci (VRE) have become one of the most problematic
groups ofmultiresistant organisms, imposing a significant burden
on the health care system, particularly in terms of controlling their
dissemination. In contrast tomany other resistant organisms, col-
onization is long term, and there is no effective method for de-
colonization. Thus, patients are likely to be committed to strin-
gent infection control precautions, potentially for life.
VRE were first isolated in Australia from a liver transplant re-
cipient in a Melbourne hospital in 1994 (12) and were first re-
ported in Queensland in 1996 (11, 16). Early studies showed that
the epidemiology of VRE in Australia was different from that ex-
perienced elsewhere, with VanB Enterococcus faecium predomi-
nating and highly polyclonal strains appearing in diverse locations
independently (3). Since then, the incidence of vancomycin-resis-
tant enterococci has escalated dramatically. A study of resistance
in isolates of Enterococcus species causing clinical disease among
in- and outpatients from 17 institutions around Australia showed
that the prevalence of vancomycin resistance in E. faecium had
more than doubled, from 7.2% in 2005 to 15.4% in 2007 (6, 7).
The prevalence of VRE colonization inQueensland has risen, with
from 0.3% of VRE screens in 2006 to 3.6% in 2011 reported to be
positive (5). VRE infection rates paralleled those for colonization,
with the incidence of enterococcal isolates from clinical specimens
identified as VRE rising from 0.1% in 2006 to 3.3% in 2011 (5).
To further complicate the situation, studies suggest that the
incidence ofmore unusual enterococcal species, such as E. durans,
E. gallinarum, and E. casseliflavus, from clinical specimens has
increased significantly (22). Although some are intrinsically resis-
tant to vancomycin, they do not pose the same infection control
concerns as E. faecium or E. faecalis VRE, as their resistance is
chromosomal rather than plasmid mediated. Their resistance to
vancomycin does, however, mean that they will grow on selective
medium designed to screen for VRE. This therefore adds to the
number of positive screens that need to be further identified. Fur-
ther, some of these more unusual enterococcal species may not be
as reliably identified by commercial identification systems (22).
The ability to promptly identify these enterococcal species cor-
rectly would greatly reduce the number of false-positive VRE
screens (growth of intrinsically resistant species on screening me-
dium containing vancomycin) that require further identification.
Bacterial identification based on spectra obtained by matrix-
assisted laser desorption ionization–time of flight mass spectrom-
etry (MALDI-TOF MS) was proposed over 30 years ago. Only
recently, it has been used as a rapid, inexpensive, and accurate
method for identifying isolates that belong to certain bacterial
phyla (19). Its application is increasing rapidly, and it is now rou-
tinely used for bacterial identification in many clinical laborato-
ries. Although the utilization of this technology for more defined
applications, including identification of antibiotic resistance, is
evolving rapidly, to our knowledge, it has not been reported for
the identification of vancomycin resistance or VRE. Changes in
mass spectra have been shown with strains of Staphylococcus au-
reus differing in their susceptibility to methicillin, even when they
were indistinguishable by pulsed-field gel electrophoresis (PFGE)
(14) (9). MALDI-TOF MS was also possibly able to detect resis-
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tance to the glycopeptide teicoplanin (14). MALDI-TOF MS has
been used for analysis of genetically determined resistance of
Streptococcus pneumoniae to fluoroquinolones, through detection
of mutations in the fluoroquinolone target structures before they
were able to be detected phenotypically (15). The methods by
which MALDI-TOFMS has previously been able to identify anti-
biotic resistance have varied; however, the method for identifica-
tion of vancomycin resistance in enterococci that we describe here
has not been previously reported.
Strain typing to determine epidemiologic relatedness is central
to outbreak management. Currently employed genotypic typing
methods include PFGE and multilocus sequence typing (MLST).
Although these have high discriminatory power, they are labor-
intensive and costly with long turnaround times, which limit their
clinical utility. The speed with which MALDI-TOF MS can ana-
lyze bacterial isolates not only for identification purposes but also
potentially for relatedness makes it an attractive alternative to
these genotypic methods. In addition to S. aureus (18, 24), some
examples of the application of MALDI-TOF MS for this purpose
include the typing of Listeria species (2), the differentiation of
Streptococcus pneumoniae isolates associated with an outbreak of
conjunctivitis (23), and the characterization and discrimination
between closely related environmental strains of Escherichia coli,
thereby enabling their classification according to source (20). To
date, however, the use ofMALDI-TOFMS for the investigation of
relatedness of enterococci has not been reported.
The C-terminal D-Ala–D-Ala residues of bacterial cell wall pre-
cursors are the target for the glycopeptide antibiotics vancomycin
and teicoplanin. Once bound, these antibiotics inhibit the trans-
glycosylation and transpeptidation reactions of peptidoglycan as-
sembly. Resistance to glycopeptides is mediated through six Van
types, the acquired VanA, VanB, VanD, VanE, and VanG and also
VanC, which is intrinsic to E. gallinarum, E casseliflavus, and E.
flavescens. Organisms of the VanA phenotype are resistant to both
vancomycin and teicoplanin, whereas vanB-positive organisms
are resistant to vancomycin only. In Australia, VanB is the more
common vancomycin-resistant phenotype. Resistance to vanco-
mycin arises from alterations in the antibiotic binding site due to
changes in the ligase gene.More specifically, the vanB gene cluster,
as described in E. faecalis V583, consists of genes encoding poly-
peptides assigned to the regulation of glycopeptide resistance
genes (vanRB and vanSB), synthesis of the depsipeptide D-alanyl–
D-lactate (vanHB and vanB), and hydrolysis of precursors of nor-
mal D-Ala–D-Ala peptidoglycan (vanXB and vanYB) (10, 17). The
fact that the upstream two-component regulatory system is in-
duced by vancomycin but not teicoplanin explains the suscepti-
bility to teicoplanin of VanB-type VRE (10).
It is postulated that any one or perhaps the combination of
these polypeptides could sufficiently alter the spectra obtained by
MALDI-TOF MS to enable the identification of vancomycin-re-
sistant enterococci, thus superseding the laborious and time-con-
suming phenotypic and molecular methods currently employed.
Our routine diagnostic microbiology laboratory is uniquely posi-
tioned in having a specialist proteomics division within the same
pathology department. We aim to utilize specialized post-data-
acquisition analysis methods available through this collaboration
to demonstrate that MALDI-TOFMS is capable of differentiating
vancomycin-sensitive from vancomycin-resistant (vanB-posi-
tive) E. faecium isolates in a much more rapid time frame than
existing methods (minutes versus days). Once this is demon-
strated, we aim to translate this information back into the routine
diagnostic laboratory to enable the rapid identification of VRE
from clinical specimens. In addition, given that the vast majority
of acquisitions occur by nosocomial spread and are often associ-
ated with outbreaks, we investigate the use of MALDI-TOFMS to
determine the epidemiologic relatedness of VRE isolates.
MATERIALS AND METHODS
Study design. Consecutive unique Enterococcus faecium isolates that were
phenotypically suspected of being and subsequently confirmed to be vanB
positive by PCR and that were collected over a continuous 18-month
period from January 2009 to June 2010 inclusive were included in the
analysis. These isolates and controls were analyzed using a Bruker micro-
flex apparatus (Bruker Daltonics GmbH, Bremen, Germany), and data
were analyzed with the proprietary software program ClinProTools to
determine the accuracy of identification using theMALDI-TOFMS tech-
nology, the relatedness of the clinical isolates, and whether MALDI-TOF
MS can be used to identify resistance to vancomycin in the form of VanB
VRE. OnceMALDI-TOFMS was shown to be able to differentiate VanB-
positive from VanB-negative enterococci, the final phase of this study
entailed prospective validation of this approach by incorporating it into
the standardwork flowof the routine diagnosticmicrobiology laboratory.
Study venue. The Division of Microbiology at Mater Misericordiae
Health Services (South Brisbane, Australia) receives specimens from the
Mater Health Services (1,060 beds), comprising Mater Adults Hospital,
Mater Mothers Hospital (public and private), Mater Children’s Hospital
(public and private), and the twoMater private hospitals (South Brisbane
and Redlands), as well as Holy Spirit Northside Private Hospital and a
number of general practice surgeries in Brisbane and surrounding areas.
TheMater Complex includes four intensive care units (adults [public and
private], children’s, and neonatal) and handles a large oncology patient
population as well as a full range of adult/maternity/pediatric and neona-
tal services.
Isolates. Consecutive VanB E. faecium isolates were recovered from
clinical specimens and from screening swabs submitted to Mater Pathol-
ogy. VREwere suspected if growthwas observed on vancomycin-resistant
enterococcal selective medium that contained bile esculin, sodium azide,
and vancomycin (6 g/ml) (BBL Enterococcosel agar; Becton, Dickinson
and Company) or resistance to vancomycin was detected during routine
susceptibility testing according to CLSI guidelines (8). Phenotypic iden-
tification was performed by conventional microbiological methods based
on colony morphology and Gram stain, a negative catalase reaction, a
positive pyrrolidonylaminopeptidase (PYR) reaction, a negative over-
night methyl--D-glucopyranoside (MGP) reaction, and absence of mo-
tility (4). Identification and susceptibility testing by broth microdilution
were performed from a subculture of the isolate using the Vitek 2 auto-
mated identification system (bioMérieux). MICs for vancomycin were
obtained by Etest as per CLSI guidelines (8).
Given the requirement for repeated subculture and the time taken for
the various components of the phenotypic identification, this method
generally takes 3 to 4 days to report the positive identification of VRE.
Although the total cost of identification of a VRE by this method is diffi-
cult to quantitate fully, particularly in terms of the scientists’ labor re-
quired, the quantifiable cost of reagents and consumables for conven-
tional identification by this phenotypic method was estimated to be
approximately AU$25 to AU$30.
Detection of VanB. Isolates phenotypically suspected of being vanco-
mycin resistantwere referred to PathologyQueensland for PCR (the “gold
standard”). PathologyQueensland utilizes amultiplex assay based on spe-
cific detection of genes encoding D-alanine–D-alanine ligases (ddl) to con-
firm identification as E. faecium or E. faecalis and VanA or VanB as part of
the National VRE Network (NaVREN) and on the primers developed by
Bell and colleagues (4).
Controls. Four control groups were utilized to identify peaks in the
mass spectra that may be attributable to the presence of vanB in E. fae-
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cium. These controls were (i) eight E. faecium isolates from a variety of
sources phenotypically suspected of being vancomycin resistant but
found to lack vanB (and vanA) by PCR by Pathology Queensland (sup-
plied by Pathology Queensland), (ii) non-VRE E. faecium reference strain
ATCC 19434, (iii) a vanA-positive E. faecium reference strain (supplied by
Jan Bell), and (iv) non-VRE E. faecalis reference strain ATCC 51299.
The eight isolates phenotypically suspected of being vancomycin re-
sistant but PCR negative were the principle negative control utilized as
they most closely control for variations attributable to components other
than the presence of vanB, such as those that determine local strains. Six of
these were suspected of being VRE on the basis of results from the Vitek 2
automated identification system (bioMérieux), and two had growth on
screening medium containing vancomycin. In addition to the absence of
both VanA and VanB determinants, the species was confirmed to be E.
faeciumwith ddl PCR (4). E. faeciumATCC 19434was included to enlarge
the negative-control population, given the small numbers of available
isolates phenotypically suspected of beingVREbut PCRnegative, as this is
a relatively rare occurrence.
PFGE. Four representative isolates obtained in the first 6 months of
the time period of the study (isolates 4, 15, 17, and 19) were randomly
selected for further analysis by PFGE (performed by Pathology Queens-
land) to enable correlation with MALDI-TOF MS relatedness analysis of
the same isolates.
MALDI-TOF MS. Two methods are commonly employed for the
preparation of bacterial isolates for MALDI-TOF MS analysis: the direct
colony method and the extraction method. The direct colony method
involves spotting a small amount of biological material (often, an individ-
ual colony) directly onto the target plate (typically onto multiple spots)
using a toothpick. Although this is the quickest and easiest method and
results in a spectral resolution sufficient for the routine identification of
most bacterial isolates, studies have shown that the physical disruption of
peptidoglycan in the Gram-positive bacterial cell wall using this method
may not be ideal to adequately prepare proteins for MALDI-TOF MS
analysis (21). The direct transfer of a colony from an agar plate to the
target may also reduce the resolution of the spectra obtained due to me-
tabolites, pigments, and/or agar potentially interfering with the crystalli-
zation process (9). An extractionmethod involves the lysis of the bacterial
cells, releasing proteins into an extract that can then be applied to the
target plate for MALDI-TOF MS analysis, and overcomes some of the
shortcomings of the direct colony method. Alatoom and colleagues com-
pared the direct colony method and the extraction method for identifica-
tion of Gram-positive cocci (including enterococci) and showed that the
proprietary extraction method was superior for the identification of iso-
lates to the genus and species levels (1). Given that the first aim of our
study was to analyze enterococci, to detect what may be very subtle dif-
ferences in the spectra obtained, and subsequently generate a reference
spectral profile against which potential VRE isolates in our laboratory will
be compared, during the initial phase of the study we utilized an extrac-
tion method to optimize the resolution of the resultant spectra.
Ethanol-formic acid extraction. The proprietary extraction method
described in the MALDI Biotyper instruction booklet (version 2.0) and
the procedure formicroorganism profiling withMALDI Biotyper prelim-
inary version/090109 were used with slight modification.
All steps were performed at room temperature. Nuclease-free water
(300 l; Qiagen) was aliquoted into a plasticizer-free 1.5-ml Eppendorf
tube, one loop of organisms from a single colonywas added, and thewater
and organismswere thoroughlymixed by vortexing. To this suspension of
organisms, 900l 100% ethanol was added, and again, the organisms and
the suspension were thoroughly mixed by vortexing. To deposit the bio-
logical material, the tubes were centrifuged at 10,000 rpm for 2 min and
the supernatant was decanted. To remove the residual ethanol, the tubes
were centrifuged again and the ethanol was removed by careful pipetting.
Twenty microliters of 70% formic acid (Fluka Analytical) was added to
the pellet, and the formic acid and pellet were well mixed by vortexing,
followed by the addition of 20 l of pure acetonitrile (Sigma-Aldrich),
whichwas carefullymixedwith the other components by pipetting up and
down. Finally, the tubes were centrifuged at 10,000 rpm for 2 min, result-
ing in a supernatant ready for analysis.
Target preparation. One microliter of supernatant was carefully
placed onto a single spot on a 96-spot polished steel target and allowed to
dry. Once dry, this was overlaid with 1 l matrix solution (a saturated
solution of -cyano-4-hydroxycinnamic acid [HCAA] matrix [Sigma-
Aldrich] in 50% acetonitrile [Sigma-Aldrich] and 2.5% trifluoroacetic
acid [Auspep]) and once again allowed to dry.
MS spectrum acquisition. MALDI-TOF MS was performed on a
Bruker Microflex LT benchtop instrument controlled by FlexControl
software (version 2.0; Bruker Daltonics GmbH, Leipzig, Germany). Spec-
tra were acquired as per the standard recommended proprietary method
utilizing the Biotyper preprocessing standard method and the Biotyper
MSP identification standard method (2,000 to 20,000 Da, linear positive
method).
Data analysis.Data acquired byMALDI-TOFMSwere analyzed using
ClinProTools (version 2.2; Bruker Daltonics GmbH, 2007) following the
generation of relevant XML files using a ClinProtSpectraImport XML
generator.Once theXMLfileswere opened inClinProTools, the datawere
prepared by recalibration, average peak list calculation, and peak calcula-
tion.
Models were generated using all four available algorithms (genetic
algorithm [GA], support vector machine [SVM], supervised neural net-
work [SNN], and QuickClassifier [QC]) and compared. For each model,
the default settings were left unaltered; for example, with the support
vector machine model, automatic detection was selected for peaks in
model and the k-nearest-neighbor (KNN) classification was left at a num-
ber of neighbors equal to 3. With the genetic algorithm, the maximum
number of peaks in the model was left at 10 and themaximum number of
generations was left at 50. For each model, the recognition capability and
cross validation were calculated to demonstrate the reliability and accu-
racy of the model.
Prospective validation. Following the completion of the statistical
analysis of the study isolates, the isolates proven to be vanB positive by
PCR and the isolates clinically suspected of being VRE but vanB PCR
negative were entered into the MALDI-TOF MS database and labeled
“VRE positive” and “VRE negative,” respectively. Comparison of isolates
analyzed by MALDI-TOF MS with these two reference spectra, in addi-
tion to the proprietary data set, allowed the identification of vancomycin
resistance in enterococci (specifically, of the VanB type) during routine
identification of isolates in the laboratory. Prospective validation of this
method was conducted in the first 2 months of 2012. To accomplish this,
all growth obtained on theVRE screeningmedium (vancomycin-resistant
enterococcal selective medium containing bile esculin, sodium azide, and
vancomycin [6 g/ml] [BBL Enterococcosel agar; Becton, Dickinson and
Company]) from screening swabs submitted to the laboratory was ana-
lyzed by MALDI-TOF MS in parallel with the conventional phenotypic
methods presented above. In addition, in our laboratory, all blood culture
isolates are analyzed by MALDI-TOF MS, so these and other clinical en-
terococcal isolates suspected of potentially being VRE were included in
the analysis. As the spectral resolution necessary to perform the higher-
level proteomic analysis and generate the reference spectra was not re-
quired when comparing clinical isolates to the reference spectra that had
been added to the database, the extraction step was not performed. Given
that the focus for routine use of MALDI-TOFMS is speed and ease of use
and that the laboratory had already validated the direct colonymethod for
the identification of clinical isolates, this method was chosen for the pro-
spective validation. This involved touching a toothpick on the colony and
spotting it directly in a circular motion onto two consecutive spots on the
polished steel target plate. Once it was dry, the smear of organisms was
overlaid with 2 l matrix solution (a saturated solution of HCAA matrix
[Sigma-Aldrich] in 50% acetonitrile [Sigma-Aldrich] and 2.5% trifluoro-
acetic acid [Auspep]) and allowed to dry. MALDI-TOF MS data acquisi-
tion was performed as previously outlined.
Griffin et al.
2920 jcm.asm.org Journal of Clinical Microbiology
 o
n
 O
ctober 22, 2015 by University of Queensland Library
http://jcm.asm.org/
D
ow
nloaded from
 
RESULTS
VRE results over the 18-month period. Sixty-seven unique VRE
isolates were identified utilizing the routine laboratory methods
outlined above with both identification as E. faecium and the pres-
ence of VanB confirmed by PCR by the reference laboratory and
therefore included in the analysis.
In addition to the 67 VanB E. faecium isolates which were ob-
tained during the study period and utilized in the subsequent
analysis, E. faecalis (as opposed to E. faecium) isolates that were
vanBpositive (representing 6%of all VREs isolated)were cultured
from four patients. Given the relatively low incidence of E. faecalis
VRE not only in this data set but also nationwide, these four iso-
lates were not analyzed. No vanA-positive isolates were identified
during the study period.
Six of the 67 isolates included in the study were obtained from
clinical specimens, and the remainder were cultured from dedi-
cated multiresistant organism (MRO) screens. Of the clinical
specimens, two were sputum samples and four were urine sam-
ples. There were a total of 13 patients whose clinical specimens
tested positive for VanB E. faecium during the study period. In
addition to the six patients in which the first specimen that was
VRE positive was a clinical sample, an additional seven patients
had a positive result for VRE from a culture of a clinical specimen
subsequent to them returning a positive MRO screen. Three of
these patients had positive blood cultures, two had positive urine
cultures, one had a positive sputumculture, and one had a positive
wound culture. The distribution by month ranged from 0 in June
2009 to 13 in October 2009, with a mean of 3.7 cases per month
(standard deviation, 3.0). During October 2009, a nosocomial
outbreak was identified on the basis of evidence of in-hospital
transmission.
Identification by MALDI-TOF MS. (i) Patient isolates.Of the
67 VRE isolates analyzed, 66 (98.5%) were identified correctly (to
the species level) by MALDI-TOF MS, according to the results of
the gold standard PCR. The mean score obtained for the 66 iso-
lates with a correct identification was 2.456 (range, 1.924 to
2.592), which, according to the proprietary key, is in the category
“highly probable species identification.” Of the 66 correctly iden-
tified, the majority (48 or 73%) were identified as Enterococcus
faecium 20218_1 CHB, with 18 identified as Enterococcus faecium
11037_CHB (27%). According to Bruker, these 2 database entries
represent different E. faecium strains obtained from the Charité
Berlin Culture Collection, so it is likely that they are similar.
The isolate that was not correctly identified by MALDI-TOF
MSwas reported to beEnterococcus gallinarumDSM20717_DSM,
with a score of 1.818, followed by Enterococcus casseliflavus DSM
20382DSM,with a score of 1.784. This isolate was cultured during
the month of peak incidence, October 2009; it was phenotypically
identified as E. faecium in our laboratory, and the ddl PCR from
the reference laboratory confirmed this. Given that the score was
belowwhat is considered an acceptable cutoff for probable species
identification (2.0 to 2.299), this result should be considered in-
complete rather than incorrect.
(ii) Controls. Of the 8 PCR-negative controls run in duplicate,
11 were identified as Enterococcus faecium 11037_CHB (69%) and
5 were identified as Enterococcus faecium 20218_1 CHB (31%),
with an average score of 2.35.
The other control isolates were analyzed each time that a VRE
isolate was analyzed, which was a total of 11 times. The VRE-
negative E. faecium control strain ATCC 19434 was identified as
Enterococcus faecium 11037_CHB 10 out of 11 times analyzed
(91%) and as Enterococcus faecium 20218_1 CHB once (9%), with
an average score of 2.40.
The E. faecalis control strain ATCC 51299 was identified as
Enterococcus faecalis 20247_4_CHB 8 out of 11 times analyzed
(73%) and as Enterococcus faecalis ATCC 7080_THL 3 out of 11
(27%), with an average score of 2.42.
The vanA-positive E. faecium isolate was identified as Entero-
coccus faecium 20218_1 CHB 10 out of 11 times analyzed (91%)
and as Enterococcus faecium 11037_CHB once (9%), with an av-
erage score of 2.42.
(iii) Overall. Of the 67 patient isolates and the 49 spots gener-
ated from the controls (a total of 116 samples analyzed), only 1
sample was not correctly identified, giving an accuracy to the spe-
cies level of 99.13%. It is clear from these results that the existing
database gives no indication of the presence of vanB (or vanA) on
the basis of the closest match in the database alone.
(iv) Data analysis on ClinProTools.Themodels generated us-
ing all four of the standard algorithms, GA, SVM, SNN, and QC,
yielded similar results.
SVM gave a higher recognition capability (effectively sensitiv-
ity) at 99.24%, compared to one of 95.12% for the GA. Cross
validation (equivalent to specificity) was similar between the two
models at 88.45% for SVM and 88.24% for GA. Use of the SNN
algorithm resulted in a slightly lower recognition capability and
cross validation (97.73% and 86.34%, respectively). Use of theQC
resulted in the lowest scores of all, with a recognition capability of
91.75% and cross validation of 79.45%. Thus, although the differ-
ences were not striking, SVM was the most reliable model for
differentiating VRE-positive from VRE-negative isolates.
Overall, the peaks or integration regions chosen for differenti-
ation of VRE status by all four of themodels were very similar. The
important peaks not only from the SVM but also from all models
were 2, 21, 23, 28, and 45; the peak statistics for these five peaks are
shown in Table 1.
(v) Peak statistics. The low P values for the Anderson-Darling
test (PAD) are evidence of the nonnormal distribution of the data
obtained. Therefore, the P value of the Wilcoxon test/Kruskal-
Wallis test (PWKW) is preferred over the P value of the t test/
ANOVA test (PTTA) (as this is preferable for normally distributed
data). The low P values obtained from PWKW (all were0.005)
indicate that the observed intensity differences of the individual
peaks are highly statistically significant and not based on coincidence
(the lower that theP value is, the better that a respective peak signal is
suited to be used to separate the two classes [13]). This confirms that
they each can be used to differentiate VRE-positive fromVRE-nega-
tive isolates. To demonstrate the differences visually, three represen-
tative peaks of interest are shown in Fig. 1 to 3, where the average
spectra of the VRE-positive and VRE-negative isolates can be seen
overlying the corresponding gel views.
(vi) Receiver operator curves. The receiver operating charac-
teristic (ROC) curves for each of the peaks of interest generated by
the SVM model were also obtained from the ClinProTools soft-
ware (Fig. 4). These curves give a graphical overview of the speci-
ficity and sensitivity of a test or, within ClinProTools, an evalua-
tion of the discrimination quality of a peak.
A perfect test with a sensitivity and a specificity of 1 would
show a ROC curve that starts at the origin (0, 0), ascends vertically
up the y axis to (0, 1), and then extends horizontally across to (1,
MALDI-TOF MS and VRE
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1). In contrast, a test with no diagnostic capability would produce
a diagonal line from the origin to (1, 1). All four of the ROC curves
shown ascend vertically from the origin for some time, before
gradually curving toward (1, 1), and are well above the diagonal
connecting (0, 0) and (1, 1) at all times. This is therefore another
representation of the ability of each peak to differentiate the vanB-
positive isolates from the controls. The area under the curve
(AUC) also demonstrates the diagnostic utility of each peak, with
an AUC of 0.5 representing pure chance and an AUC of 1 indicat-
ing a perfect test (sensitivity and specificity, 100%). The AUCs of
the ROCs for peaks 2, 23, 28, and 45 are 0.895, 0.706, 0.848, and
0.814, respectively (Fig. 4).
(vii) Internal validation. To internally validate the SVM
model generated by ClinProTools, two-thirds of both the VRE-
positive and VRE-negative isolates were randomly allocated to
form a discovery set, to enable the remaining third of isolates from
both cohorts to function as a validation set. To that end, 44 of the
PCR-confirmed vanB isolates were randomly allocated into the
discovery set with 18 PCR-negative isolates. The validation set
therefore comprised the remaining 22 positive isolates with the
remaining 9 controls. After the calculation of the SVMmodel, the
validation was performed using the validation function in Clin-
ProTools. This procedure was performed three times. From the
three internal validations, the average sensitivity was 92.4% and
the average specificity was 85.2%.
(viii) Differentiating VanA from VanB. Comparisons be-
tween the vanA- and vanB-positive isolates using the SVMmodel
produced a cross validation (essentially, specificity) of 95.04%and
a recognition capability (basically, sensitivity) of 100%. The peak
with the highest weighting was peak 36, with a mass of 6,603 Da;
the average spectra, gel view, and ROC can be seen in Fig. 5. It was
clear that vanA-positive E. faecium and vanB-positive E. faecium
isolates are readily distinguishable by MALDI-TOF MS analysis.
(ix) Prospective validation. A total of 281 spots from 129 sam-
ples were successfully analyzed as part of the prospective valida-
tion of the use of MALDI-TOF MS to detect vancomycin resis-
tance in enterococci (specifically, of the VanB type) during
January and February 2012. Themajority (271 or 96%)were from
screening swabs, with 5 clinical specimens analyzed (in duplicate).
Of the 281 spots analyzed, 274 (97.5%) were correctly identified
byMALDI-TOFMS compared to the results of conventional phe-
notypic methods. Only 7 (2.5%) were incorrectly identified, with
4 (1.4%) false negatives and 3 (1.1%) false positives, resulting in a
sensitivity of 96.7% and a specificity of 98.1%.
Strain relatedness. The study period included an outbreak
during which time it was clinically relevant to investigate whether
all VRE isolates were identical or whether new strains were intro-
duced and contributed to the outbreak. To that end, four isolates
were sent to the reference laboratory for PFGE analysis. All four
VRE strains analyzed by PFGE were indistinguishable from each
other and from the reference outbreak strain, strain A1, from the
reference laboratory.
(i) MALDI-TOF MS to investigate relatedness. To investigate
whether MALDI-TOF MS in conjunction with ClinProTools
could establish relatedness, hierarchical cluster analysis was per-
formed in ClinProTools on all 66 isolates positive for vancomycin
resistance; the dendrograms produced are shown in Fig. 6 and 7.
The four isolates shown to be identical by PFGE and to refer-
ence outbreak strain A1 were demonstrated to be related by
MALDI-TOF MS hierarchical cluster analysis when analyzed in
isolation, with a maximum separation of 1.7 (Fig. 6). Although all
werewithin the similarity cutoff of 2.5, themagnified dendrogram
suggests that isolates 4 and 19 and isolates 17 and 15 are more
closely related to each other than to the isolates in the other pair.
Hierarchical cluster analysis of the 66 vanB PCR-positive VRE
isolates correctly identified byMALDI-TOFMS is shown in Fig. 7.
Given that themonth of October 2009 contributed the peak num-
ber of VRE isolates to the cohort analyzed, the 12 isolates from this
month correctly identified as E. faecium (the incorrectly identified
isolate was also cultured during this month) are also indicated.
This dendrogram suggests, on the basis of the arbitrary similarity
cutoff of 2.5, that there may have been four strains or related
clusters that contributed cases during the study period. Close ex-
amination of the isolates cultured during the peak month of Oc-
tober 2009 shows that themajority (n 9) cluster closely together
at the bottom of the dendrogram, with a second cohort compris-
ing three isolates appearing in the top cluster. This suggests that a
second strain may have been introduced or contributed cases to
the outbreak that occurred in October 2009.
DISCUSSION
These results indicate thatMALDI-TOFMS can easily and reliably
distinguish between E. faecium isolates that are vanB positive and,
hence, vancomycin resistant and those that are not. It also shows
that this technology is likely to be able to indicate the relatedness
of strains of this organism to a degree similar to the existing gold
standard for analyzing relatedness, PFGE.
Of the clinical isolates analyzed in this study, themajority were
obtained from urine specimens, with the rate of bacteremia in
colonized patients being 4.5%. This is comparable to the findings
TABLE 1 ClinProTools peak statistics for the five peaks of interesta
Index
peak Mass DAve PTTA PWKW PAD Avg1 Avg2 SD1 SD2 CV1 CV2
2 2,211.5 3.63  0.000001  0.000001 0.612 10.1 6.48 2.67 1.66 26.4 25.6
21 4,717 2.6 0.0000888 0.000656 0.000729 6.21 3.61 3.21 2 51.7 55.3
23 5,094.7 8.95  0.000001 0.00359  0.000001 11.3 2.39 8.68 1.64 76.5 68.6
28 5,945.7 2.97 0.00012 3.94E-06  0.000001 3.09 6.06 1.29 2.94 41.9 48.5
45 8,327.9 1.52 8.47E-06 0.000038 0.175 4.07 2.56 1.26 1.12 30.9 43.9
a Sort mode, delta average arithmetic; index, peak index or isolate number; mass,m/z value; DAve, difference between the maximal and the minimal average peak area/intensity of
all classes; PTTA, P value of t test; PWKW, P value of Wilcoxon (preferable for nonnormally distributed data); PAD, P value of Anderson-Darling test, which gives information
about normal distribution (range, 0 to 1; 0, nonnormally distributed; 1, normally distributed); Avg1 and Avg2, peak area/intensity average of class 1 (the VREs) and class 2 (the
non-VREs), respectively; SD1 and SD2, standard deviations of the peak area/intensity average of class 1 (the VREs) and class 2 (the non-VREs), respectively; CV1 and CV2,
coefficient of variation (in percent) of class 1 (the VREs) and class 2 (the non-VREs), respectively.
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FIG 1 (a) Representative comparison of the average spectra of the vanB-positive E. faecium isolates (green) and the vanB-negative E. faecium isolates (isolates
phenotypically suspected of being VRE yet PCR negative and control strain ATCC 19434) (red) between 2,160 Da and 2,720 Da; (b) corresponding gel view
representation (rainbow-scale color scheme) of the same region. The peak with a mass of 2,211 Da is peak 2 used in the classification model. arb. u., arbitrary
units; Sp. #, spectrum number.
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FIG 2 (a) Representative comparison of the average spectra of the vanB-positive E. faecium isolates (green) and the vanB-negative E. faecium isolates (isolates
phenotypically suspected of being VRE yet PCR negative and control strain ATCC 19434) (red) between 5,000 Da and 5,240 Da; (b) corresponding gel view
representation (blue-scale color scheme) of the same region. vanB-positive E. faecium isolates (bottom) and vanB-negative E. faecium isolates (isolates pheno-
typically suspected of being VRE yet PCR negative and control strain ATCC 19434) (top). The peak with a mass of 5,095 Da is peak 23 used in the classification
model and is essentially not present in the control samples. arb. u., arbitrary units; Sp. #, spectrum number.
Griffin et al.
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FIG 3 (a) Representative comparison of the average spectra of the vanB-positive E. faecium isolates (green) and the vanB-negative E. faecium isolates (isolates
phenotypically suspected of being VRE yet PCR negative and control strain ATCC 19434) (red) between 5,916 Da and 6072 Da; (b) corresponding gel view
representation (gray-scale color scheme) of the same region. vanB-positive E. faecium isolates (bottom) and vanB-negative E. faecium isolates (isolates pheno-
typically suspected of being VRE yet PCR negative and control strain ATCC 19434) (top). The peak with a mass of 5,945 Da is peak 28 used in the classification
model. arb. u., arbitrary units; Sp. #, spectrum number.
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of other studies, including data from the local statewide public
hospital laboratory information system (the Centre for Health-
care Related Infection Surveillance and Prevention) that demon-
strated that the majority of the increase in VRE infections in
Queensland was of the urinary tract (5). On the basis of annually
adjusted data from the first 7 months of 2011, they found a higher
bacteremia rate of 11%.
The significant increase in cases identified in our facility in
October 2009 not only is a manifestation of the increased trans-
mission due to the outbreak at that time but also is likely due to
increased detection resulting from increased screening imple-
mented as part of outbreak management. In this facility, routine
screening does not occur in all clinical areas, and it is likely that the
true number of cases at other times may have been slightly higher
than that reported. During nonoutbreak times, routine screening
occurred only in high-risk units and on patients transferred from
other hospitals.
The low score of 1.818 obtained from the isolate incorrectly
identified as Enterococcus gallinarum DSM 20717_DSM suggests
that theremay have been a problemwith the extraction process or
the preparation of the spot of the extract on the target plate. As the
aim of this study was to establish the ability ofMALDI-TOFMS to
correctly identify VRE E. faecium, this was not repeated, as repeat-
ing it would have compromised the validity of the results. In rou-
tine application, however, a sample with a result such as this
should be retested.
There is already a VRE in the proprietary database, Enterococ-
cus faecium VRE (PX) 16086218_MLD. This was not closely
matched to any of the isolates analyzed in this study, and it is not
known whether this is a VanA or a VanB VRE strain (Bruker
Daltonics GmbH, personal communication). Therefore, had we
relied on the ability of the MALDI-TOF MS with the proprietary
software to identify vancomycin resistance in the form of VRE,
none of the isolates would have been correctly identified.
The support vector machines model was shown to be the most
reliable for differentiating the VRE-positive isolates from the neg-
ative controls utilizing ClinProTools. This is in keeping with the
method utilized by this model. Support vector machines is an
algorithm for the determination of optimal separating planes be-
tween different data classes using formal approaches fromoptimi-
zation theory to separate the given data sets. The fact that different
models chose to utilize essentially the same peaks adds strength to
the argument that the peaks chosen are able to differentiate be-
tween the two cohorts analyzed.
The receiver operator curves, including the AUCs, indicate
that each of peaks 2, 23, 28, and 45would be satisfactory diagnostic
FIG 4 ROC curves of four of the peaks of interest generated from the SVM model showing the discrimination quality of the individual peaks.
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tests for separating the vanB-positive isolates from the controls. It
is important to point out that the diagnostic capability ofMALDI-
TOF MS is actually a combination of not only these peaks dis-
played but a profile that includes these in addition to many other
peaks analyzed simultaneously.
Despite the internal validation showing that the sensitivity and
specificity of the model for differentiating the isolates with or
without the VRE phenotype were high (92.4% and 85.2%, respec-
tively), the power of this calculation is reduced by nature of the
way in which it is calculated. Internal validation results in an un-
derrepresentation of the power of themodel as a whole, due to the
reduction in sample size required to generate a discovery set that
leaves isolates to be allocated to the validation set. If the same
isolates were consistently incorrectly classified in each of the three
validations, then this would represent a flaw in the data (and in-
dicate that those isolates were likely misidentified). This was not
the case, however, as the VRE-positive isolates and the controls
that were incorrectly classified were different in each of the three
validations. This is therefore likely to be simply a reflection of the
reduced power of the internal validation.
Once the ability of MALDI-TOFMS to distinguish the vanco-
FIG 5 (a) Representative comparison of the average spectra of the vanB-positive E. faecium isolates (red) and the vanA-positive E. faecium controls (green)
between 6,460 Da and 6,830 Da; (b) corresponding gel view representation (rainbow-scale color scheme) of the same region. vanB-positive E. faecium isolates
(bottom) and vanA-positive E. faecium controls (top); the peak with amass of 6,603 Da is peak 36 used in the classificationmodel; (c) corresponding ROC curve
for peak 36. arb. u., arbitrary units; Sp. #, spectrum number.
FIG 6 Magnified dendrogram (representation of hierarchical cluster analysis)
of the four vanB-positive E. faecium isolates from our laboratory shown to be
identical by PFGE and their representative numbers. All four isolates are well
within the arbitrary relatedness cutoff of 2.5.
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mycin-resistant vanB-positive E. faecium isolates from the PCR-
negative controls was established from the study isolates, a pro-
spective validation of the use ofMALDI-TOFMS for this purpose
in the routine clinical microbiology laboratory was successfully
completed. The finding that in routine use, with themodifications
to the database, MALDI-TOFMS has a sensitivity of 96.7% and a
specificity of 98.1%has a number of significant implications. First,
it enhances the relevance of our findings to the routine diagnostic
laboratory, whereby a number of operatorswere able to utilize this
technology to obtain results that were comparable to those ob-
tained by the more labor-intensive, time-consuming, and expen-
sive method currently utilized. This demonstrates that the use of
MALDI-TOF MS is not restricted to just a few highly specialized
operators, as is the case with most molecular methods. It also
significantly increased the sample size to which our method was
applied to enhance the validity of our findings. The results from
the prospective validation show that there were only 3 false-posi-
tive spots of the 281 analyzed. The false-positive spots were from
two patient specimens, with one of these having multiple other
samples positive by both conventional means and MALDI-TOF
MS, so this is more likely to be a false-negative result by conven-
tionalmethods than a false-positive result byMALDI-TOFMS. In
addition, there were only four false-negative results during the
entire prospective validation period. It can be seen that although it
was used for generating the reference spectra and the initial high-
er-level proteomic analysis, themore laborious extractionmethod
is not required for the successful identification of vancomycin
resistance in clinical specimens. This greatly enhances the rele-
vance of our findings to the routine diagnostic laboratory,
whereby the extraction method would negate the benefits of
FIG 7 Dendrogram (representation of hierarchical cluster analysis) of all 66 vanB PCR-positive patient isolates. The four vanB-positive E. faecium isolates from
our laboratory shown to be identical by PFGE are shown by their representative number. The 12 vanB-positive isolates from the month with peak incidence
(October 2009) are also shown. The vertical line indicates the similarity cutoff of 2.5 arbitrarily chosen for MALDI-TOF MS group definition.
Griffin et al.
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MALDI-TOF MS, as it adds significant time and cost to each iso-
late analyzed. These results show that for routine use the direct
colonymethod produces results that are comparable to those pro-
duced by phenotypic methods, and it has successfully passed a
prospective validation in comparison to currently laboratory
practice that is beyond the level required for local regulatory bod-
ies. Hence, it has been incorporated into routine laboratory prac-
tice as the method of choice.
Currently, growth on screening medium with chromosomal
van gene-positive species of enterococci (such as in E. gallinarum)
occurs reasonably frequently; this technology is shown here to be
able to very easily distinguish these chromosomal van gene-posi-
tive species of enterococci from E. faecium isolates by correctly
identifying the organisms to the species level over 99% of the time
and far more rapidly and cost-effectively than the current pheno-
typic methods employed. There were 44 intrinsically vancomy-
cin-resistant enterococcal species analyzed as part of the pro-
spective validation, and not 1 tested falsely positive for VRE
utilizing this methodology.
The implications of this study are significant.Without the abil-
ity to detect vanB-positive E. faecium isolates using molecular
methods, our laboratory (and many others) currently relies on a
lengthy and costly phenotypic method to identify likely VRE iso-
lates. The requirement for repeated subculturing adds significant
time to this process; a positive result can often be reported only on
day 3 or 4 after receipt of the specimen. With the procedure de-
scribed here, it is feasible that VRE isolates can be determined as
soon as growth is evident on the screening medium, which often
occurs less than 24 h after the specimen is received. In addition to
the cost savings in reduced laboratory scientist time and the con-
sumables required (including multiple agar plates, Etests, Vitek
cards, etc.), the ability to more rapidly implement appropriate
infection control precautions has significant implications for con-
trol of nosocomial infections. Although not addressed specifically
by this study, it seems reasonable to hypothesize that a rapid di-
agnostic test forVREhas the potential to reduce spread to the staff,
hospital environment, and other patients that the positive case
would have come into contact with during the period that current
procedures would have taken to confirm the presence of VRE. The
converse is also likely, that saving on very costly infection control
precautions by more rapidly declaring a patient negative could
result in a significant saving. Rapid diagnosis thus has the poten-
tial to turn a disease that is currently an increasing burden into
something that may be more controllable.
This work also shows the potential for MALDI-TOF MS to
demonstrate the relatedness of isolates using hierarchical cluster
analysis, a function that can be useful in an outbreak situation to
ascertain whether cases are a result of transmission of local strains
or possibly contributed to by new imported strains. Hierarchical
cluster analysis utilizes the cluster algorithm to determine the re-
latedness between individual measurements, in this case, the MS
spectrum, of each isolate. Spectra aremerged in successive rounds
of analysis until only one measurement remains. The merging
patterns of spectra are then represented as a dendrogram or tree
structure. Since spectra are merged by relatedness, the distance of
branches on the tree or dendrogram relates directly to the similar-
ity of spectra and, hence, the similarity of bacterial isolates.
It can be difficult to confirm or refute relatedness in an organ-
ism that is so polyclonal; however, this work suggests that
MALDI-TOF MS performs comparably to the current gold stan-
dard, PFGE.
The four isolates shown to be identical by PFGE were also
shown to be closely related byMALDI-TOFMS, particularlywhen
analyzed in isolation (Fig. 6).
Figures 6 and 7 show that, despite appearing to be identical by
PFGE, isolates 15 and 17 and isolates 4 and 19 appear to be more
closely related to each other than the other pair. This could be a
manifestation of the resolution of MALDI-TOF MS exceeding
that of PFGE in terms of differentiating isogenic strains, showing
subtle differences that are not evident on PFGE, which has previ-
ously been shown to be the case (14). There were no processing or
technical reasons that could otherwise explain this relationship. In
order to produce this dendrogram (Fig. 6), these four isolates were
analyzed on the same target on the same run. If relevant to the
outcome of this study, this apparent relationship between isolates
4 and 19 and isolates 17 and 15 could possibly be more firmly
established utilizing a leave-one-outmethod, whereby each one of
the four isolates is excluded and the hierarchical cluster analysis is
performed repeatedly, ensuring that the same relationship is ap-
parent in a reproducible fashion. Given that this has no bearing on
the outcome of the study, this was not performed.
Hierarchical cluster analysis of all of the VanB-positive isolates
(Fig. 7) suggested that there may have been four strains or related
clusters that contributed isolates during the study period. It is not
surprising that there appear to be multiple strains or clusters, as
VRE in Australia have generally been shown to be highly poly-
clonal and appear in diverse locations independently (3). This
dendrogram also suggests that a second cluster may have contrib-
uted cases to the outbreak that occurred in October 2009. This
finding is clinically relevant, because if the analysis had been per-
formed in real time, it could have significantly altered the infec-
tion control response. The four isolates shown to be identical by
PFGE are actually spread across two clusters, where the division
actually exceeds three on this dendrogram. It is likely that this is
simply a reflection of the hierarchical cluster analysis of such a
uniform population. The relationship between isolates 4 and 19
and isolates 15 and 17 still holds true, as both of these pairs are
clustered together well within the similarity cutoff of 2.5. Thus,
although PFGE was not performed on all isolates, it may be that
the differences between seemingly unrelated isolates by MALDI-
TOF MS in this population may still be similar by PFGE.
A larger sample size of isolates subjected to an alternative typ-
ing method would allow more inferences to be made about the
ability of MALDI-TOFMS to determine relatedness compared to
the ability of other methods. The limitations of the alternative
methods, such as PFGE, including cost, requirement for special-
ized staff, long turnaround times, and, as such, limited availability,
meant that this was not possible for this study.
Ideally, when comparing the relationship between isolates us-
ing hierarchical cluster analysis, all isolates would be analyzed at
the same time following identical processing, including identical
incubation times on the same medium and simultaneous extrac-
tion. Given the date range and number of isolates, this was not
feasible. This does not seem to have affected the data presented,
however, as the isolates have not grouped according to when they
were analyzed.
One limitation of this study is the separation in time and loca-
tion of the molecular gold standard assay and our proteomics-
based assay. An issue with comparison of proteomic methods to
MALDI-TOF MS and VRE
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genomic methods is that the presence of the genotype does not
always correlate linearly with the phenotype. Ideally, the same
isolate would have been subjected to both MALDI-TOF MS and
PCR analysis without any subculture and from the same medium
under the same conditions; however, this was not possible. It is
possible that during transport or subculture the expression of the
genes of interest could be up- or downregulated or even lost. It
appears from these results that this has not significantly affected
the outcome.
The relatively small sample size of the PCR-negative control
cohort is another limitation of our study. Unfortunately, given
that this negative-control group was comprised of isolates pheno-
typically suspected of beingVanBpositive yet beingVanBnegative
by PCRby the reference laboratory, which is a relatively rare event,
the number of isolates available was very limited. To address this,
other VRE-negative organisms were also analyzed (and analyzed
repeatedly, a total of 11 times each), and the PCR-negative isolates
were analyzed in duplicate. Although it is not statistically valid to
combine the results of the initial phase of the investigation with
the prospective validation results, when looking at the results of
the two phases of the study together, the number of true positives
(n  186; 67 PCR-positive isolates and 119 phenotypically con-
firmed isolates) and true negatives (n  204; 16 from the PCR-
negative but phenotypically suspected group, 33 from the other
negative controls utilized in the initial phase of the study, and 155
phenotypically confirmed to be VRE negative in the prospective
validation) shows that sufficient analysis has been performed to be
confident of the findings of this study.
Further characterization of the proteins accounting for the
peaks used to identify VRE in this study, usingmore sophisticated
proteomic techniques, is possible. Given that it does not contrib-
ute to the ability of MALDI-TOF MS to identify VRE, which was
the primary aim of this study, this is not presented here.
This work adds to the mounting number of applications of
MALDI-TOFMS in a way that has enormous implications for the
diagnosis and, therefore, control of the significant nosocomial
multiresistant organism VRE. The results of this study show that
as well as being much more rapid (minutes as opposed to days)
and far cheaper (approximately AU$0.12 as opposed to at least
AU$25 in consumable cost per isolate), MALDI-TOF MS is a
highly sensitive and specific method for identifying resistance to
vancomycin in enterococci compared to conventional phenotypic
methods. Collaboration with proteomics scientists allowed exten-
sion of this technology beyond the capabilities of the routine di-
agnostic laboratory to perform a sophisticated analysis that has
not previously been described in a form such as this. Subse-
quently, the knowledge gained was able to be translated back into
the diagnostic lab, where it has had a tremendous impact. The
robustness of the identification of vancomycin resistance in en-
terococci described in this study was due in part to our access to
proteomics expertise and informatics tools. It is our hope that
now that we have demonstrated the validity of this approach,
other laboratories can follow to create their own unique resistance
signatures, possibly even without the need for specialized assis-
tance. Even though this study focused on the particular VREprob-
lematic in our country, the principles presented herein are able to
be replicated to readily address any VRE (E. faecium or E. faecalis
andVanAorVanB) and could potentially even be extrapolated for
use for the rapid identification of other multiresistant organisms
with similar resistance mechanisms.
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